CLIMB BIO INC. - COMMON STOCK

1.2700

28-April-25 10:24:11

15 minutes delayed

Stocks

0.0000

0.00%

Today's range

1.2600 - 1.3100

ISIN

N/A

Source

NASDAQ

Eliem Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference

11 Feb 2022 07:00:00 By Nasdaq GlobeNewswire
Eliem Therapeutics Host Virtual Investor Event Featuring Opinion Leaders in Chronic Pain Research on February 16, 2022

07 Feb 2022 07:00:00 By Nasdaq GlobeNewswire
Eliem Therapeutics Provides Program Updates and an Overview of Expected Near-Term Milestones

18 Jan 2022 07:00:01 By Nasdaq GlobeNewswire
Eliem Therapeutics Reports Third Quarter Financial and Business Highlights

08 Nov 2021 16:01:00 By Nasdaq GlobeNewswire
Eliem Therapeutics to Participate at Four Upcoming Investor Conferences

04 Nov 2021 07:00:01 By Nasdaq GlobeNewswire
Eliem Therapeutics Reports Second Quarter Financial Results

13 Sep 2021 16:10:00 By Nasdaq GlobeNewswire
Eliem Therapeutics Announces Closing of Initial Public Offering with Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

12 Aug 2021 21:06:11 By Nasdaq GlobeNewswire
Eliem Therapeutics Announces Pricing of Initial Public Offering

09 Aug 2021 22:33:09 By Nasdaq GlobeNewswire

<<
<
1
2
3
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.